# Neuroprotection by Cannabinoids in Huntington's Disease

> **NCT01502046** · PHASE2 · COMPLETED · sponsor: **Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal** · enrollment: 25 (actual)

## Conditions studied

- Huntington's Disease

## Interventions

- **DRUG:** delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01502046
- **Lead sponsor:** Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2013-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01502046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01502046, "Neuroprotection by Cannabinoids in Huntington's Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01502046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*